Načítá se...
Delivering bioactive cyclic peptides that target Hsp90 as prodrugs
The most challenging issue facing peptide drug development is producing a molecule with optimal physical properties while maintaining target binding affinity. Masking peptides with protecting groups that can be removed inside the cell, produces a cell-permeable peptide, which theoretically can maint...
Uloženo v:
| Vydáno v: | J Enzyme Inhib Med Chem |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6407599/ https://ncbi.nlm.nih.gov/pubmed/30822267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2019.1580276 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|